Both, model 3 and model 4, considering CD8+ cell density indicators in combination with clinicopathologic variables and conventional BC IHC indicators, respectively, revealed that tumor invasion stage 2 was associated with worse BCSS, while elevated CD8+ density in the IZ stroma aspect correlated with better BCSS. The gene discussed is CD8A; the disease is breast cancer.